Review



phospho explorer antibody array  (Full Moon BioSystems)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Full Moon BioSystems phospho explorer antibody array
    <t>Proteomic</t> profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.
    Phospho Explorer Antibody Array, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+array/phospho+explorer+antibody+array/pmc11977646-108-0-11
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis"

    Article Title: Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis

    Journal: Molecular Oncology

    doi: 10.1002/1878-0261.13788

    Proteomic profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.
    Figure Legend Snippet: Proteomic profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.

    Techniques Used: Expressing, Selection, Comparison



    Similar Products

    phospho explorer antibody array pex100  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody array pex100
    Phospho Explorer Antibody Array Pex100, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+array/phospho+explorer+antibody+array/bio_rxiv__2025__07__12__664538-56-1-6
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array pex100 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    phospho explorer antibody arrays  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody arrays
    Phospho Explorer Antibody Arrays, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+array/phospho+explorer+antibody+array/10__1016_slash_j__phymed__2025__156660-98-1-8
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody arrays - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes)  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes)
    Phospho Explorer Antibody Array Containing 1318 Antibodies (With 99% Reactivity Against Human Epitopes), supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+array/phospho+explorer+antibody+array/pmc11937680-381-5-16
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array containing 1318 antibodies (with 99% reactivity against human epitopes) - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    phospho explorer antibody array cat. no. pex100  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody array cat. no. pex100
    Phospho Explorer Antibody Array Cat. No. Pex100, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+array/phospho+explorer+antibody+array/10__1007_slash_s10068___025___01822___1-108-7-14
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array cat. no. pex100 - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    phospho explorer antibody array  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho explorer antibody array
    <t>Proteomic</t> profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.
    Phospho Explorer Antibody Array, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho+explorer+array/phospho+explorer+antibody+array/pmc11977646-108-0-11
    Average 90 stars, based on 1 article reviews
    phospho explorer antibody array - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Proteomic profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.

    Journal: Molecular Oncology

    Article Title: Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis

    doi: 10.1002/1878-0261.13788

    Figure Lengend Snippet: Proteomic profiling of EWS primary tumors and metastases reveals a distinct protein expression profile. (A) Example of a tumor (left) and a metastasis (right) chip from the Phospho Explorer array. Green fluorescent intensity indicative of protein expression (lighter = more expression). (B) Venn diagram indicating, from the total number of proteins present in the array (1320), which proteins were detected in each sample group. In the overlap (proteins detected in both sample groups), the list of proteins that passed the selection criteria (0.5 < FC >2; blue = tumors, red = metastases). (C) Comparison of each pair of A673 tumor‐metastasis, indicating the proteins detected in each subset and those shared. From these, the list and FC expression values are shown for those that passed selection criteria. In bold, those shared in 2/3 metastases. Red = higher expression in metastases; Blue = higher expression in tumors. Samples analyzed; n = 6. EWS, Ewing sarcoma; FC, fold change.

    Article Snippet: Proteomic expression analyses were done using the Phospho Explorer Antibody Array (Full Moon Biosystems, TebuBio, Le Perray en Yvelines, France).

    Techniques: Expressing, Selection, Comparison